| News & Announcements | Coverage for Low Frequency Ultrasound Treatment for Wound Management for Commercial Members | | | | | | 7/1/2024 | | | |
| News & Announcements | 7/01/2024 CPT & HCPCS Quarterly Code Update Coverage Determinations for Commercial Products | | | | | | 7/1/2024 | | | |
| News & Announcements | Pemivibart (Pemgarda) for Pre-Exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) for Commercial Members | | | | | | 7/3/2024 | | | |
| Notifications | Electromyography (EMG) Studies, Nerve Conduction Studies (NCS), and Related Electrodiagnostic Studies | 07.03.09v | 7/2/2024 10:00 AM | 9/30/2024 | | | 7/9/2024 | Medical Necessity Criteria;Medical Coding;General Description, Guidelines, or Informational Update | | |
| Notifications | Intraoperative Neurophysiological Monitoring (INM) | 07.03.14r | 7/2/2024 8:00 AM | 9/30/2024 | | | 7/9/2024 | Medical Coding | | |
| Notifications | Lower Limb Prostheses | 05.00.59o | 7/12/2024 5:00 PM | 8/12/2024 | | | 7/12/2024 | Coverage and/or Reimbursement Position | | |
| Notifications | Proton Beam Radiation Therapy (Independence Administrators) | 09.00.49n | 7/30/2024 3:00 PM | 10/28/2024 | | | 7/30/2024 | Medical Necessity Criteria | | |
| New Policies | ADAMTS13, recombinant-krhn (Adzynma) | 08.02.21 | | 7/15/2024 | | | 7/15/2024 | This is a New Policy. | | |
| New Policies | Toripalimab-tpzi (LOQTORZI™) | 08.02.20 | | 7/15/2024 | | | 7/15/2024 | This is a New Policy. | | |
| Updated Policies | Preventive Care Services | 00.06.02ar | 6/1/2024 10:00 AM | 7/1/2024 | | | 7/1/2024 | Medical Necessity Criteria;Medical Coding | | |
| Updated Policies | Self-Administered Drugs and Biologics | 08.00.78ar | | 7/1/2024 | | | 7/1/2024 | Coverage and/or Reimbursement Position;Medical Coding | | |
| Updated Policies | Speech Therapy | 10.06.01m | | 7/1/2024 | | | 7/1/2024 | Medical Necessity Criteria;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Chiropractic Spinal and Extraspinal Manipulation Therapy | 10.02.02k | | 7/1/2024 | | | 7/1/2024 | Medical Necessity Criteria;Medical Coding;General Description, Guidelines, or Informational Update | | |
| Updated Policies | eviCore Lab Management (Independence) | 06.02.52ag | 5/31/2024 11:00 AM | 7/1/2024 | | | 7/1/2024 | Coverage and/or Reimbursement Position;Medical Necessity Criteria;Medical Coding;General Description, Guidelines, or Informational Update | 7/1/2024 | |
| Updated Policies | PPO Network Rules for Provision of Specialty Services for Durable Medical Equipment and Laboratory, Radiology, and Physical Medicine and Rehabilitative Services | 00.01.25bo | | 7/1/2024 | | | 7/1/2024 | Coverage and/or Reimbursement Position | | |
| Updated Policies | Betibeglogene Autotemcel [Beti-Cel (ZYNTEGLO®)] | 08.01.89a | | 7/1/2024 | | | 7/1/2024 | General Description, Guidelines, or Informational Update | | |
| Updated Policies | Intravenous Ketamine (Ketalar®) and Intranasal Esketamine (Spravato®) | 08.01.80c | | 7/1/2024 | | | 7/1/2024 | Medical Necessity Criteria | | |
| Updated Policies | Biofeedback Therapy | 07.00.01n | | 7/1/2024 | | | 7/15/2024 | Coverage and/or Reimbursement Position;Medical Necessity Criteria;Medical Coding;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Beremagene Geperpavec (Vyjuvek™) | 08.02.10b | | 7/15/2024 | | | 7/15/2024 | Medical Coding;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Etranacogene dezaparvovec-drlb (Hemgenix®) | 08.02.03a | | 7/15/2024 | | | 7/15/2024 | Medical Coding;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Valoctocogene roxaparvovec-rvox (ROCTAVIAN™) | 08.02.09b | | 7/15/2024 | | | 7/15/2024 | General Description, Guidelines, or Informational Update | | |
| Updated Policies | Orthoptic/Pleoptic Training | 07.13.01k | | 7/15/2024 | | | 7/15/2024 | Coverage and/or Reimbursement Position | | |
| Updated Policies | Ramucirumab (Cyramza®) | 08.01.25h | | 7/15/2024 | | | 7/15/2024 | Medical Necessity Criteria;Medical Coding;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Assisted Reproductive Technology for Infertility and Oocyte Cryopreservation | 07.10.06j | | 7/15/2024 | | | 7/15/2024 | Medical Necessity Criteria | | |
| Updated Policies | Routine/Non-routine Vaccines | 08.01.04ad | | 7/1/2024 | | | 7/26/2024 | Medical Necessity Criteria;Medical Coding | | |
| Updated Policies | Colorectal Cancer Screening | 11.03.12u | | 7/29/2024 | | | 7/29/2024 | Medical Necessity Criteria;Medical Coding | | |
| Updated Policies | Experimental/Investigational Services | 12.01.01bm | | 7/1/2024 | | | 7/29/2024 | Medical Coding | | |
| Updated Policies | Octreotide Acetate (Sandostatin® LAR Depot) | 08.01.10i | | 7/29/2024 | | | 7/29/2024 | Medical Necessity Criteria | | |
| Updated Policies | Fam-trastuzumab deruxtecan-nxki (Enhertu®) | 08.00.12g | | 7/29/2024 | | | 7/31/2024 | Medical Necessity Criteria;Medical Coding | | |
| Reissue Policies | Wheelchair Cushions and Seating | 05.00.55k | | 8/14/2023 | 6/26/2024 | | 7/8/2024 | | | |
| Reissue Policies | Golimumab (Simponi Aria®) Intravenous (IV) Injection | 08.01.15g | | 10/30/2023 | 7/10/2024 | | 7/10/2024 | | | |
| Reissue Policies | Cobalamin (Vitamin B12), Folic Acid, and Homocysteine Testing | 06.02.54c | | 10/1/2022 | 7/10/2024 | | 7/10/2024 | | | |
| Reissue Policies | Immune Cell Function Assay | 06.02.37a | | 11/6/2015 | 7/10/2024 | | 7/10/2024 | | | |
| Reissue Policies | In Vitro Chemosensitivity and Chemoresistance Assays | 06.02.14i | | 1/1/2020 | 7/10/2024 | | 7/10/2024 | | | |
| Reissue Policies | Nerve Fiber Density Testing | 06.02.38d | | 1/1/2019 | 7/10/2024 | | 7/10/2024 | | | |
| Reissue Policies | Testing Serum Vitamin D Levels | 06.02.51d | | 10/1/2020 | 7/10/2024 | | 7/10/2024 | | | |
| Reissue Policies | Home Oxygen Therapy | 05.00.58o | | 7/17/2023 | 7/10/2024 | | 7/10/2024 | | | |
| Reissue Policies | Percutaneous Left Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation | 11.02.26c | | 7/18/2022 | 7/10/2024 | | 7/10/2024 | | | |
| Reissue Policies | Nonemergent Inpatient Video Electroencephalogram (EEG) Monitoring and Ambulatory EEG Monitoring in the Home | 07.03.25a | | 1/1/2020 | 7/10/2024 | | 7/10/2024 | | | |
| Reissue Policies | Medical Necessity | 12.01.02b | | 1/1/2024 | 7/10/2024 | | 7/10/2024 | | | |
| Reissue Policies | Fecal Microbiota Transplantation (FMT) | 07.05.08d | | 7/1/2023 | 7/10/2024 | | 7/10/2024 | | | |
| Reissue Policies | Total Artificial Hearts (TAHs) | 11.02.19g | | 3/13/2023 | 7/10/2024 | | 7/10/2024 | | | |
| Reissue Policies | Mentoplasty or Genioplasty | 11.14.01h | | 10/1/2023 | 7/10/2024 | | 7/10/2024 | | | |
| Reissue Policies | Ostomy Supplies | 05.00.50o | | 6/30/2023 | 7/10/2024 | | 7/10/2024 | | | |
| Reissue Policies | Cryosurgical Ablation of the Prostate Gland | 11.11.03d | | 4/6/2015 | 6/26/2024 | | 7/16/2024 | | | |
| Reissue Policies | Lipectomy and Liposuction | 11.08.03m | | 10/9/2023 | 7/24/2024 | | 7/24/2024 | | | |
| Reissue Policies | Repository Corticotropin Injection (Acthar® Gel, Purified Cortrophin[TM] Gel) | 08.01.12e | | 1/2/2024 | 7/24/2024 | | 7/24/2024 | | | |
| Reissue Policies | Tofersen (Qalsody®) | 08.02.06a | | 1/1/2024 | 7/24/2024 | | 7/24/2024 | | | |
| Reissue Policies | Home-Based Sleep Studies | 07.03.01c | | 10/1/2023 | 7/24/2024 | | 7/24/2024 | | | |
| Reissue Policies | Steroid-Eluting Sinus Stents and Implants | 11.16.08f | | 9/13/2021 | 7/24/2024 | | 7/24/2024 | | | |
| Reissue Policies | Contact Lenses for the Treatment of Persistent (Corneal) Epithelial Defects | 07.13.11k | | 10/1/2021 | 7/24/2024 | | 7/24/2024 | | | |
| Reissue Policies | Repair of Cleft Lip, Cleft Nose, and/or Cleft Palate | 11.03.01f | | 12/21/2020 | 7/24/2024 | | 7/24/2024 | | | |
| Reissue Policies | Enzyme Replacement Therapy for Adenosine Deaminase Severe Combined Immune Deficiency (e.g., elapegademase-lvlr [Revcovi]) | 08.01.26d | | 8/30/2021 | 7/24/2024 | | 7/24/2024 | | | |
| Reissue Policies | Rhytidectomy and/or Cervicoplasty With or Without Liposuction and/or Platysmaplasty | 11.08.13g | | 5/19/2017 | 7/24/2024 | | 7/24/2024 | | | |
| Reissue Policies | Complete Decongestive Therapy (CDT) | 07.06.01b | | 12/30/2013 | 7/24/2024 | | 7/24/2024 | | | |
| Reissue Policies | Trigger Point Injections | 11.14.02r | | 4/1/2024 | 7/24/2024 | | 7/24/2024 | | | |
| Coding Update | Wound Care: Skin Substitutes for the Treatment of Burns and Chronic, Non-Healing Wounds | 11.08.20al | | 7/1/2024 | | | 7/1/2024 | | | |
| Coding Update | Coverage of Anticancer Prescription Oral and Injectable Drugs and Biologics and Supportive Agents | 08.01.08q | | 7/1/2024 | | | 7/1/2024 | | | |
| Coding Update | Efbemalenograstim alfa-vuxw (Ryzneuta®), Eflapegrastim-xnst (Rolvedon™), Pegfilgrastim (Neulasta®) and Related Biosimilars | 08.01.32m | | 7/1/2024 | | | 7/1/2024 | | | |
| Coding Update | Elective Abortion | 11.06.02n | | 7/1/2024 | | | 7/1/2024 | | | |
| Coding Update | Chimeric Antigen Receptor (CAR) Therapy | 08.01.43m | | 7/1/2024 | | | 7/1/2024 | | | |
| Coding Update | Telemedicine Services | 00.10.41m | | 7/1/2024 | | | 7/1/2024 | | | |
| Coding Update | Electromyography (EMG) (Needle and Non-Needle) of the Anal or Urethral Sphincter | 07.03.21n | 7/2/2024 3:00 PM | 10/1/2023 | | | 7/3/2024 | | 7/3/2024 | |
| Coding Update | Always Bundled Procedure Codes | 00.01.52v | | 7/1/2024 | | | 7/8/2024 | | | |
| Coding Update | Modifiers 26 (Professional Component) and TC (Technical Component) | 03.00.20s | | 7/1/2024 | | | 7/9/2024 | | | |
| Coding Update | Modifier 50: Bilateral Procedure | 03.00.05y | | 7/1/2024 | | | 7/11/2024 | | | |
| Coding Update | Modifier 62: Two Surgeons | 00.10.11z | | 7/1/2024 | | | 7/11/2024 | | | |
| Coding Update | Modifiers for Assistant-at-Surgery Services: 80, 81, 82, and AS | 00.10.18x | | 7/1/2024 | | | 7/11/2024 | | | |
| Coding Update | Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease | 08.01.93d | | 7/2/2024 | | | 7/19/2024 | | | |
| Archived Policies | Nerve Conduction Studies (NCS) and Related Electrodiagnostic Studies | 07.03.18t | 7/2/2024 3:00 PM | 9/30/2024 | | | 7/2/2024 | | | |
